Article Information
vol. 53 no. 3
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 2, 2018
- Accepted December 11, 2018
- Published online March 18, 2019.
Article Versions
- previous version (February 14, 2019 - 02:00).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©ERS 2019
Author Information
- Pauline T. Lukey1,
- Stephen A. Harrison1,
- Shuying Yang1,
- Yim Man1,
- Beverley F. Holman2,
- Alaleh Rashidnasab2,
- Gabrielle Azzopardi2,
- Michael Grayer1,
- Juliet K. Simpson1,
- Philippe Bareille1,
- Lyn Paul3,
- Hannah V. Woodcock4,
- Richard Toshner3,
- Peter Saunders3,
- Philip L. Molyneaux3,5,
- Kris Thielemans2,
- Frederick J. Wilson1,
- Paul F. Mercer4,
- Rachel C. Chambers4,
- Ashley M. Groves2,
- William A. Fahy1,
- Richard P. Marshall1 and
- Toby M. Maher3,5⇑
- 1GlaxoSmithKline Research and Development, Stevenage, UK
- 2University College London, Institute of Nuclear Medicine, London, UK
- 3NIHR Respiratory Clinical Research Facility, Royal Brompton Hospital, London, UK
- 4University College London, Centre for Inflammation and Tissue Repair, London, UK
- 5Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK
- Toby M. Maher, Fibrosis Research Group, Inflammation, Repair and Development Section, NHLI, Sir Alexander Fleming Building, Imperial College, London SW7 2AZ, UK. E-mail: t.maher{at}imperial.ac.uk
Funding
GlaxoSmithKline